Journal of Cancer Therapy
Vol.6 No.8(2015), Paper ID 58366, 9
pages
DOI:10.4236/jct.2015.68074
Efficacy and Safety of Axitinib as First-Line Therapy in Japanese Patients with Metastatic Renal Cell Carcinoma
Takeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, Masayuki Kobayashi, Takayuki Ohzeki, Yosuke Sato, Junryo Rii, Hirotsugu Uemura, Tomohiko Ichikawa, Takeshi Ueda
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Department of Urology, Kinki University Hospital, Osaka, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Department of Urology, Kinki University Hospital, Osaka, Japan
Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan
Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan
Copyright © 2015 Takeshi Namekawa, Satoshi Fukasawa, Atsushi Komaru, Masayuki Kobayashi, Takayuki Ohzeki, Yosuke Sato, Junryo Rii, Hirotsugu Uemura, Tomohiko Ichikawa, Takeshi Ueda et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Namekawa, T. , Fukasawa, S. , Komaru, A. , Kobayashi, M. , Ohzeki, T. , Sato, Y. , Rii, J. , Uemura, H. , Ichikawa, T. and Ueda, T. (2015) Efficacy and Safety of Axitinib as First-Line Therapy in Japanese Patients with Metastatic Renal Cell Carcinoma.
Journal of Cancer Therapy,
6, 670-678. doi:
10.4236/jct.2015.68074.